Vitamin D3 for Life

Live Enlightened

Article

Vitamin A and the Calcium Response to Calcitriol: Study Summary

Previous related pageVitamin A and the Calcium Response to Calcitriol: Full StudyNext related pageVitamin D and Age-Related Decline
Study at a glance

How was vitamin A tested alongside active vitamin D?

Nine healthy adults each received four treatments on separate occasions: an inactive treatment, retinyl palmitate, calcitriol, and both together. The order was random and participants and researchers did not know which treatment was being given. Retinyl palmitate is a form of vitamin A. Calcitriol is active vitamin D, which differs from ordinary vitamin D3 supplements. Blood samples were collected the following day.

How did vitamin A change the blood calcium response?

Average adjusted blood calcium rose by 2.3% after calcitriol and 1.4% after the combination compared with the inactive treatment. Vitamin A alone lowered it by 1.0%. The combination’s rise was significantly smaller than the rise with calcitriol alone, but it was not eliminated. Adding vitamin A did not detectably change the fall in parathyroid hormone. No significant changes were found in the measured bone-breakdown or urinary-calcium markers.

Do the results explain why blood calcium changed?

No. Blood calcium is influenced by several processes. Intestinal absorption was proposed as an explanation but was not measured directly. Separate laboratory receptor experiments used a different vitamin A-related compound and did not prove the mechanism in these volunteers. A large observational study found no overall association between vitamin A intake and fractures after adjustment; a smaller-group finding remained uncertain and did not establish cause and effect.

Can these findings guide long-term vitamin supplement use?

This was a small, short experiment, not a study of long-term bone health or ordinary supplement use. It did not establish fracture effects, an ideal vitamin ratio, a dose threshold or a timing rule. The findings do not justify removing normal vitamin A foods, copying the research treatment or using vitamin A to counter suspected vitamin D toxicity.

Read the full article below ↓

A small human experiment found that retinyl palmitate, a form of vitamin A, reduced the short-term blood-calcium rise caused by calcitriol. That finding is narrower than a claim that ordinary vitamin A intake blocks vitamin D₃ supplements or causes fractures. The distinction rests on the compounds administered, the measurements made and the time scale studied.

What was tested?

In Johansson and Melhus’s 2001 randomised, double-blind crossover, nine healthy adults completed four separate treatment occasions: placebo, retinyl palmitate, calcitriol, and their combination. A crossover means each participant experiences every treatment and supplies their own comparison. There were four men and five women, aged 24 to 41, with at least 14 days between occasions.

The tested doses were 15 mg retinyl palmitate and 2 µg calcitriol. Calcitriol is the active vitamin D hormone, 1,25-dihydroxyvitamin D₃. It is different from the cholecalciferol found in ordinary vitamin D₃ supplements, which must first undergo the stages described in Vitamin D Activation. The doses cannot be treated as interchangeable preparations.

Participants took the preparations at night. Five blood samples were collected the following day, around standardised meals. The investigators compared average post-dose measurements with each person’s placebo-day measurements. This was a short physiological experiment, not a long-term supplementation trial.

What changed?

Albumin-adjusted serum calcium rose by 2.3% with calcitriol and by 1.4% with the combination, relative to placebo. Retinyl palmitate alone produced a 1.0% decrease. The combination’s rise was significantly smaller than the rise with calcitriol alone, with p<0.05. It nevertheless remained a rise: vitamin A diminished this response rather than abolishing it.

Parathyroid hormone fell after calcitriol, but adding retinyl palmitate did not detectably change that response. No significant treatment effects were found for the measured bone-resorption marker or urinary calcium relative to creatinine. The result therefore concerns a particular calcium response, not demonstrated suppression of every effect of active vitamin D.

What was not measured?

Serum calcium is a concentration in blood, influenced by several organs and regulatory processes. It is not a direct measure of intestinal calcium absorption. The investigators proposed an intestinal explanation, but they did not use calcium tracers to measure absorption or trace calcium into the skeleton. Vitamin D and Calcium Physiology explains the broader system behind the blood measurement.

The trial also did not measure fracture risk, bone-density change or long-term outcomes. Nine participants can provide a useful within-person comparison, but cannot establish whether the finding applies equally to children, older adults, deficient populations or people with disease. No dose-response series established a threshold, optimal ratio or supplement timing rule.

How does the supporting evidence fit?

A receptor experiment by Thompson and colleagues showed that a retinoic acid ligand could modify vitamin D receptor-complex binding to DNA under controlled laboratory conditions. That supplies a possible molecular explanation, not proof that the same process caused the calcium change in the volunteers. Retinoic acid in that experiment and retinyl palmitate in the human trial were different exposures.

A large Women’s Health Initiative observational analysis found no overall association between vitamin A or retinol intake and hip or total fractures after full adjustment. A modest total-fracture association in the lower vitamin D-intake subgroup was more limited and depended on analysis choices. Estimated dietary intake was not a blood measurement, and the study did not randomise the nutrients.

Together, the studies show why a nutrient interaction needs a defined level of explanation. Molecular binding, serum chemistry and fractures are related questions, but evidence at one level cannot automatically establish the next. Vitamin D in Nutrient Networks places these relationships in the broader nutritional context.

What should the reader take from it?

The acute interaction is a legitimate finding worth understanding. Its clinical implications remain less certain. It does not justify removing normal sources of vitamin A, converting the research doses into a supplement combination, or using vitamin A to counter suspected vitamin D toxicity.

For the treatment comparisons, measurement limits, receptor evidence and fracture analysis, continue to Vitamin A and the Calcium Response to Calcitriol: Full Study.

Primary source and publication details

Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, Snetselaar LG, Chen Z. Vitamin A and retinol intakes and the risk of fractures among participants of the Women’s Health Initiative Observational Study. The American Journal of Clinical Nutrition. 2009;89:323 to 330. DOI: 10.3945/ajcn.2008.26451. PMID: 19056568.

Related reading

Original sources

Source

Heterodimeric DNA Binding by the Vitamin D Receptor and Retinoid X Receptors Is Enhanced by 1,25-Dihydroxyvitamin D3 and Inhibited by 9-cis-Retinoic Acid: Evidence for Allosteric Receptor Interactions

Published in Journal of Biological Chemistry (1998).

Publication details

Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR. Heterodimeric DNA Binding by the Vitamin D Receptor and Retinoid X Receptors Is Enhanced by 1,25-Dihydroxyvitamin D3 and Inhibited by 9-cis-Retinoic Acid: Evidence for Allosteric Receptor Interactions. Journal of Biological Chemistry. 1998;273:8483 to 8491. DOI: 10.1074/jbc.273.14.8483. PMID: 9525962.

Read more →